Cargando…
High-Risk Neuroblastoma Treatment Review
Neuroblastoma is the most common extracranial solid tumor in children. One subset, high-risk neuroblastoma, is very difficult to treat and requires multi-modal therapy. Intensification of therapy has vastly improved survival rates, and research is focused on novel treatments to further improve survi...
Autores principales: | Smith, Valeria, Foster, Jennifer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162495/ https://www.ncbi.nlm.nih.gov/pubmed/30154341 http://dx.doi.org/10.3390/children5090114 |
Ejemplares similares
-
Treatment of High-Risk Neuroblastoma
por: Krystal, Julie, et al.
Publicado: (2023) -
Treatment of high-risk neuroblastoma
por: Sung, Ki Woong
Publicado: (2012) -
Neuroblastoma in the Era of Precision Medicine: A Clinical Review
por: Wahba, Andrew, et al.
Publicado: (2023) -
Spotlight on dinutuximab in the treatment of high-risk neuroblastoma: development and place in therapy
por: Keyel, Michelle E, et al.
Publicado: (2018) -
Small Molecules Targeting INSM1 for the Treatment of High-Risk Neuroblastoma
por: Lan, Michael S., et al.
Publicado: (2023)